<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font19">and </span>
   <span class="font16">{background </span>
   <span class="font16">for </span>
   <span class="font16">fragments </span>
   <span class="font14">margin </span>
   <span class="font14">{border-style </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">are </span>
   <span class="font13">Mpro </span>
   <span class="font13">drug </span>
   <span class="font13">were </span>
   <span class="font13">The </span>
   <span class="font13">have </span>
   <span class="font13">with </span>
   <span class="font12">fragment </span>
   <span class="font12">that </span>
   <span class="font12">from </span>
   <span class="font12">covalent </span>
   <span class="font11">drugs </span>
   <span class="font11">molecule </span>
   <span class="font11">shown </span>
   <span class="font11">small </span>
   <span class="font11">structures </span>
   <span class="font11">which </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">all </span>
   <span class="font11">inhibitors </span>
   <span class="font11">not </span>
   <span class="font11">px; </span>
   <span class="font11">this </span>
   <span class="font11">{font-family </span>
   <span class="font11">can </span>
   <span class="font11">cysteine </span>
   <span class="font11">discovery </span>
   <span class="font11">font-size </span>
   <span class="font11">multiple </span>
   <span class="font11">will </span>
   <span class="font11">active </span>
   <span class="font11">bind </span>
   <span class="font11">could </span>
   <span class="font11">double; </span>
   <span class="font11">more </span>
   <span class="font11">researchers </span>
   <span class="font11">against </span>
   <span class="font11">binding </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">clinical </span>
   <span class="font11">first </span>
   <span class="font11">has </span>
   <span class="font11">into </span>
   <span class="font11">main </span>
   <span class="font11">solid; </span>
   <span class="font11">still </span>
   <span class="font11">they </span>
   <span class="font11">two </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Douangamath </span>
   <span class="font10">active-site </span>
   <span class="font10">al. </span>
   <span class="font10">al.Discovery </span>
   <span class="font10">approved </span>
   <span class="font10">bold </span>
   <span class="font10">but </span>
   <span class="font10">chemical </span>
   <span class="font10">compounds </span>
   <span class="font10">courier; </span>
   <span class="font10">em; </span>
   <span class="font10">experimental </span>
   <span class="font10">its </span>
   <span class="font10">kinase </span>
   <span class="font10">molecules </span>
   <span class="font10">noncovalent </span>
   <span class="font10">one </span>
   <span class="font10">other </span>
   <span class="font10">potent </span>
   <span class="font10">pt;} </span>
   <span class="font10">screening </span>
   <span class="font10">some </span>
   <span class="font10">starting </span>
   <span class="font10">steps </span>
   <span class="font10">than </span>
   <span class="font10">these </span>
   <span class="font10">three </span>
   <span class="font10">using </span>
   <span class="font10">was </span>
  </p>
 </body>
</html>
